The B-cell-specific src-family kinase Blk is dispensable for B-cell development and activation

Molecular and Cellular Biology

Volumn 20, Issue 4, 2000, Pages 1227-1233

  Texido, Gemma ^a,c   Su, I Hsin ^a   Mecklenbräuker, Ingrid ^a   Saijo, Kaoru ^a   Malek, Sami N ^b   Desiderio, Stephen ^b   Rajewsky, Klaus ^a   Tarakhovsky, Alexander ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE ACTIVATION; BONE MARROW; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DISRUPTION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; ANTIBODY FORMATION; ANTIGENS, T-INDEPENDENT; B-LYMPHOCYTES; BASE SEQUENCE; CELL DIFFERENTIATION; DNA PRIMERS; FEMALE; GENE TARGETING; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, KNOCKOUT; PHOSPHORYLATION; RNA, MESSENGER; SRC-FAMILY KINASES; T-LYMPHOCYTES;

EID: 0033969955     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.4.1227-1233.2000     Document Type: Article

References (26)

1. Anderson, J. S., M. Teutsch, Z. Dong, and H. H. Wortis. 1996. An essential role for Bruton's tyrosine kinase in the regulation of B-cell apoptosis. Proc. Natl. Acad. Sci. USA 93:10966-10971.
2. Appleby, M. W., J. D. Kerner, S. Chien, C. R. Maliszewski, S. Bondada, R. M. Perlmutter, and S. Bondadaa. 1995. Involvement of p59fynT in interleukin-5 receptor signaling. J. Exp. Med. 182:811-820.
3. Chan, V. W., I. Mecklenbräuker, I. Su, G. Texido, M. Leitges, R. Carsetti, C. A. Lowell, K. Rajewsky, K. Miyake, and A. Tarakhovsky. 1998. The molecular mechanism of B cell activation by toll-like receptor protein RP-105. J. Exp. Med. 188:93-101.
4. Chan, V. W., F. Meng, P. Soriano, A. L. DeFranco, and C. A. Lowell. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7:69-81.
5. Cheng, A. M., B. Rowley, W. Pao, A. Hayday, J. B. Bolen, and T. Pawson. 1995. Syk tyrosine kinase required for mouse viability and B-cell development. Nature 378:303-306.
6. Dymecki, S. M., J. E. Niederhuber, and S. V. Desiderio. 1990. Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. Science 247: 332-336.
7. 2+ following B-cell receptor activation. EMBO J. 17:1973-1985.
8. + B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur. J. Immunol. 17:521-528.
9. Hibbs, M. L., D. M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S. A. Stacker, and A. R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83:301-311.
10. Islam, K. B., H. Rabbani, C. Larsson, R. Sanders, and C. I. Smith. 1995. Molecular cloning, characterization, and chromosomal localization of a human lymphoid tyrosine kinase related to murine Blk. J. Immunol. 154: 1265-1272.
11. Krieg, A. M. 1996. An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA. J. Lab. Clin. Med. 128:128-133.
12. Kühn, R., K. Rajewsky, and W. Müller. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707-710.
13. Kurosaki, T., M. Takata, Y. Yamanashi, T. Inazu, T. Taniguchi, T. Yamamoto, and H. Yamamura. 1994. Syk activation by the Src-family tyrosine kinase in the B cell receptor signaling. J. Exp. Med. 179:1725-1729.
14. Leitges, M., C. Schmedt, R. Guinamard, J. Davoust, S. Schaal, S. Stabel, and A. Tarakhovsky. 1996. Immunodeficiency in protein kinase c β-deficient mice. Science 273:788-791.
15. Maizels, N., J. C. Lau, P. R. Blier, and A. Bothwell. 1988. The T-cell independent antigen, NP-ficoll, primes for a high affinity IgM anti-NP response. Mol. Immunol. 25:1277-1282.
16. Malek, S. N., D. I. Dordai, J. Reim, H. Dintzis, and S. Desiderio. 1998. Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase. Proc. Natl. Acad. Sci. USA 95:7351-7356.
17. Miltenyi, S., W. Müller, W. Weichel, and A. Radbruch. 1990. High gradient magnetic cell separation with MACS. Cytometry 11:231-238.
18. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kilamura, D. Ilic. S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3:549-560.
19. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376:352-355.
20. Sambrook, T., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
21. Saouaf, S. J., S. Mahajan, R. B. Rowley, S. A. Kut, J. Fargnoli, A. L. Burkhardt, S. Tsukada, O. N. Witte, and J. B. Bolen. 1994. Temporal differences in the activation of three classes of non-transmembrane protein tyrosine kinases following B-cell antigen receptor surface engagement. Proc. Natl. Acad. Sci. USA 91:9524-9528.
22. Sefton, B. M., and J. A. Taddie. 1994. Role of tyrosine kinases in lymphocyte activation. Curr. Opin. Immunol. 6:372-379.
23. Takata, M., and T. Kurosaki. 1996. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ2. J. Exp. Med. 184:31-40.
24. Wasserman, R., Y. S. Li, and R. R. Hardy. 1995. Differential expression of the blk and ret tyrosine kinases during B lineage development is dependent on Ig rearrangement. J. Immunol. 155:644-651.
25. Yao, X. R., and D. W. Scott. 1993. Antisense oligodeoxynucleotides to the blk tyrosine kinase prevent anti-mu-chain-mediated growth inhibition and apoptosis in a B-cell lymphoma. Proc. Natl. Acad. Sci. USA 90:7946-7950.
26. Yasue, T., H. Nishizumi, S. Aizawa, T. Yamamoto, K. Miyake, C. Mizoguchi, S. Uehara, Y. Kikuchi, and K. Takatsu. 1997. A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5. Proc. Natl. Acad. Sci. USA 94:10307-10312.